Compare S&P500 ETF (SPY) vs Zoetis Inc (ZTS) Price & Performance

S&P500 ETFTrade

Zoetis IncTrade

Price performance (Past 24H)

Key statistics

S&P500 ETF vs Zoetis Inc — how do they compare? S&P500 ETF trades at $763.5, while Zoetis Inc trades at $73.65 (market cap $30.40B). The key difference: Zoetis Inc pays a 2.88% dividend while S&P500 ETF pays none, and S&P500 ETF is trading nearer its 52-week high, Zoetis Inc nearer its low. Which is the better fit depends on your goals.

	SPY	ZTS
52-Week High	$777.82	$150.61
52-Week Low	$631.99	$71.91
Market Cap	—	$30.40B
Sector	—	Health
Enterprise Value	—	$37.96B
Dividend Yield	—	2.88%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

S&P500 ETF

SPY trades at $766.00, down 0.55% on the day, with a neutral technical signal and bullish moving averages. Support levels are near $760, while resistance sits at $769. The ETF shows no available valuation ratios like P/E or P/B in the data. A dividend of $1.90 is scheduled for payment on July 31, 2026.

Outlook remains mixed amid market volatility from geopolitical tensions and oil price surges. Risks include Fed rate-hike concerns and high valuations, but AI-driven earnings growth offers potential upside. Investors should weigh resilience against near-term headwinds for long-term positioning.

Zoetis Inc

Zoetis (ZTS) trades at $73.60, down 2.92% amid bearish technical signals and mixed earnings. The stock faces pressure from weakening U.S. companion animal sales and competitive headwinds, though profitability remains strong with 71.67% gross margins and 27.69% net income margin. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a guidance cut. Analyst consensus is divided with 45% Buy ratings and a $93.40 price target, suggesting 27% upside from current levels.

The outlook balances valuation appeal (P/E of 12) against near-term operational challenges. Investment opportunity lies in market dominance and robust cash flow generation, while risks include sustained pet health demand softness and competitive pricing pressure. The stock trades near support at $73, with institutional sentiment mixed amid recent portfolio adjustments.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SPY

Memory chip stocks rise as Goldman Sachs says sector's worst downturn may be over.24/7 Wall Street · 21 hours agoBullish S&P 500 set to rebound with 8,000 target despite rising rates, driven by strong earnings growth.Seeking Alpha · 22 hours agoBullish Safe bond funds lost money over 5 years, showing cautious investing can be risky for young investors.24/7 Wall Street · 22 hours agoNeutral View details →

ZTS

Michael Burry makes Lululemon his largest portfolio bet amid market volatility.Finbold · 1 day agoBearish 4-Factor Dividend Growth Strategy slightly outperforms SCHD with 14.89% returns, testing new variants.Seeking Alpha · 3 days agoBullish View details →

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.